Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Linical Co., Ltd. ( (JP:2183) ) has issued an update.
Linical Co., Ltd. reported a significant decline in its financial performance for the nine months ending December 31, 2024, with a 14% drop in net sales compared to the previous year. The company also faced operating and ordinary income losses, alongside a negative profit attributable to its owners, indicating a challenging economic environment and potentially impacting its market positioning and stakeholder confidence.
More about Linical Co., Ltd.
Linical Co., Ltd. is a company listed on the Tokyo Stock Exchange, focusing on providing comprehensive clinical research services. It operates in the healthcare and pharmaceutical industry, offering solutions that support the clinical development and regulatory approval processes.
Average Trading Volume: 48,225
Technical Sentiment Consensus Rating: Buy
Current Market Cap: Yen7.86B
Learn more about 2183 stock on TipRanks’ Stock Analysis page.